Compare Illumina, Inc. (ILMN) vs Super Group (SGHC) Limited Ordinary Shares (SGHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? Illumina, Inc. trades at $278 (market cap $39.95B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.33 (market cap $5.86B). The key difference: Illumina, Inc. is far larger — about 6.8× Super Group (SGHC) Limited Ordinary Shares's market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.73% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Super Group (SGHC) Limited Ordinary Shares for 1 Days on average.
| ILMN | SGHC | |
|---|---|---|
Market Cap | $39.95B | $5.86B |
Volume | 3,169,503 | 1,905,788 |
Sector | Health | Consumer Cyclical |
52-Week High | $293.69 | $15.59 |
52-Week Low | $91.00 | $8.52 |
Typical Hold Time | 83 Days | 1 Days |
Enterprise Value | $41.31B | $5.41B |
Dividend Yield | — | 1.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $278.17, up 3.89% today and near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent inclusion in the S&P 500 and positive analyst upgrades reflect growing institutional confidence. Revenue remains stable at $4.34B for 2025 with improved profitability, delivering $850M net income after previous losses.
The outlook remains positive with sequencing growth and AI initiatives driving momentum, though elevated valuation ratios and China market headwinds present risks. Analyst consensus leans bullish with 54% buy ratings, but the current price exceeds the $241 consensus target, suggesting near-term consolidation potential before further upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Super Group (SGHC) Limited Ordinary Shares
Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →
